Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:23 AM
Ignite Modification Date:
2025-12-25 @ 3:23 AM
NCT ID:
NCT05717205
Eligibility Criteria:
Inclusion Criteria:
* Type 1 diabetes
* age 18-85
* Case group: Gastroparesis verified by technetium scintigraphy and a GCSI score ≥ 1.9
* Control group: Gastroparesis not confirmed by technetium scintigraphy and score GCSI score \< 1.9
Exclusion Criteria:
* Ongoing cancer treatment or other concurrent illness that will make the patient unable to attend the study on the discretion of the investigator.
* Recent gastrointestinal surgery
* Active duodenal/gastric ulcer disease,
* Diseases in the ventricle or previously complicated upper abdominal surgery
* Pregnancy or breast feeding
* Persons who, in the judgement of the investigator, may be unable to follow the protocol.
* Parkinson disease
* metoclopramide 48 hours prior to scintigraphy
* domperidone 48 hours prior to scintigraphy
* macrolide antibiotics 48 hours prior to scintigraphy
* anti-cholinergic agents
* Tricycliv antidepressants
* Glucagon-like peptide-1 analogues
* Lithium
* Diphenhydramine
* dopamine agonists
* progesterone, L-dopa
* calcitonine
* ocreotide
* Interferon alfa
* sucralsulfate
* botulinum toxin injections (eg, Botox®) by pyloric injection.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT05717205
Study Brief:
Protocol Section:
NCT05717205